These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24698492)

  • 21. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier.
    Rivers EP; Jaehne AK; Nguyen HB; Papamatheakis DG; Singer D; Yang JJ; Brown S; Klausner H
    Shock; 2013 Feb; 39(2):127-37. PubMed ID: 23324881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locally available & natural therapeutic foods for immunomodulation in protein energy malnutrition.
    Elizabeth KE
    Indian J Med Res; 2007 Sep; 126(3):179-81. PubMed ID: 18037710
    [No Abstract]   [Full Text] [Related]  

  • 24. The failure of biologics in sepsis: where do we stand?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S45-7. PubMed ID: 23664229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's New in Shock, August 2014?
    Chen P; Jeschke MG
    Shock; 2014 Aug; 42(2):83-5. PubMed ID: 25025821
    [No Abstract]   [Full Text] [Related]  

  • 26. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria.
    Graw RG; Herzig G; Perry S; Henderson ES
    N Engl J Med; 1972 Aug; 287(8):367-71. PubMed ID: 4557780
    [No Abstract]   [Full Text] [Related]  

  • 27. What's your call? Polymicrobial sepsis.
    Sendi P; Graber P; Lötscher R
    CMAJ; 2006 Aug; 175(5):475-7. PubMed ID: 16940263
    [No Abstract]   [Full Text] [Related]  

  • 28. What's new in Shock? November 2013.
    Guillory A; Finnerty CC
    Shock; 2013 Nov; 40(5):349-51. PubMed ID: 24135665
    [No Abstract]   [Full Text] [Related]  

  • 29. What's new in Shock, July 2011?
    Wischmeyer P
    Shock; 2011 Jul; 36(1):1-4. PubMed ID: 21677556
    [No Abstract]   [Full Text] [Related]  

  • 30. What's new in Shock? September 2013.
    Sherwood E
    Shock; 2013 Sep; 40(3):163-5. PubMed ID: 23949390
    [No Abstract]   [Full Text] [Related]  

  • 31. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
    J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What'S New in SHOCK, June 2017?
    Brenner M; Wang P
    Shock; 2017 Jun; 47(6):661-665. PubMed ID: 28505019
    [No Abstract]   [Full Text] [Related]  

  • 34. Round table conference on clinical trials for the treatment of sepsis. Brussels, March 12-14, 1994.
    Sibbald WJ; Vincent JL
    Intensive Care Med; 1995 Feb; 21(2):184-9. PubMed ID: 7775701
    [No Abstract]   [Full Text] [Related]  

  • 35. What's new in surgical oncology: impact of immunology and tumour biology.
    Heys SD; Eremin O
    J R Coll Surg Edinb; 1990 Dec; 35(6):341-4. PubMed ID: 2086793
    [No Abstract]   [Full Text] [Related]  

  • 36. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enigma of sepsis.
    Riedemann NC; Guo RF; Ward PA
    J Clin Invest; 2003 Aug; 112(4):460-7. PubMed ID: 12925683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's new in Shock, October 2010?
    Shahrokhi S; Jeschke MG
    Shock; 2010 Oct; 34(4):323-6. PubMed ID: 20844409
    [No Abstract]   [Full Text] [Related]  

  • 40. What's new in critical care and metabolism.
    Rice CL
    J Am Coll Surg; 1996 Feb; 182(2):93-9. PubMed ID: 8564056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.